当前位置:首页 - 行情中心 - 瑞普生物(300119) - 财务分析 - 资产负债表

瑞普生物

(300119)

  

流通市值:64.41亿  总市值:89.37亿
流通股本:3.35亿   总股本:4.65亿

资产负债表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
流动资产:
  货币资金486,904,900.47532,964,024.05451,404,509.87487,366,788.05
  交易性金融资产1,306,801,332.21,326,172,881.781,468,033,933.151,451,255,182.59
  应收票据及应收账款1,063,343,120.71,100,972,432.971,115,237,832.891,070,218,782.15
  其中:应收票据27,517,345.7523,624,351.0811,097,244.1530,429,747.69
        应收账款1,035,825,774.951,077,348,081.891,104,140,588.741,039,789,034.46
  应收款项融资17,901,174.4214,935,076.4412,267,033.567,522,354.59
  预付款项114,400,386.91108,822,448.5587,343,417.9761,196,517.9
  其他应收款合计102,581,705.3272,919,033.2367,049,332.0360,184,615.41
  其中:应收利息---1,055,138.87
  存货505,796,956.07532,354,914.76511,261,875.85499,573,319.96
  其他流动资产14,373,740.6811,961,526.0412,860,194.3411,651,981.93
  流动资产合计3,612,103,316.773,701,102,337.823,725,458,129.663,648,969,542.58
非流动资产:
  长期应收款1,621,766.371,955,408.771,336,892.121,455,756.02
  长期股权投资1,148,889,057.321,098,769,083.341,093,106,799.381,068,859,364.7
  其他非流动金融资产53,494,000.8566,263,636.26116,644,534.04100,368,039.13
  投资性房地产34,468,439.1435,466,666.2236,464,893.2737,463,120.35
  固定资产1,561,341,603.221,783,072,833.151,808,249,950.521,845,590,552.43
  在建工程99,571,615.4464,431,375.7475,275,598.5362,690,187.68
  使用权资产11,355,878.2313,227,765.1815,038,380.0617,371,440.42
  无形资产447,174,489.78474,453,435.94485,690,665.29493,138,512.76
  开发支出199,407,334.35201,691,230.81197,421,816.35192,998,232.44
  商誉442,473,678.38443,364,365.47443,364,365.47442,263,365.47
  长期待摊费用1,460,809.81,188,024.251,000,398.55944,104.11
  递延所得税资产29,873,629.7329,923,471.6227,955,377.5726,948,735.01
  其他非流动资产47,652,629.5740,071,235.4435,337,389.926,732,100.77
  非流动资产合计4,078,784,932.184,253,878,532.194,336,887,061.054,316,823,511.29
  资产总计7,690,888,248.957,954,980,870.018,062,345,190.717,965,793,053.87
流动负债:
  短期借款736,812,759.18883,745,457.48735,362,949.66800,781,866.94
  应付票据及应付账款488,861,492.51514,862,401.23641,048,294.4550,239,664.56
  其中:应付票据168,182,006.68197,445,747.08284,209,449.39187,368,279.18
        应付账款320,679,485.83317,416,654.15356,838,845.01362,871,385.38
  预收款项5,589,870.48,099,700.67,177,492.078,316,964.05
  合同负债50,846,163.9942,368,244.1538,211,941.548,111,143.45
  应付职工薪酬36,353,709.8237,523,741.0939,257,793.2567,194,592.49
  应交税费43,550,835.7335,976,619.725,070,276.4224,556,844.81
  其他应付款合计272,684,825.22393,285,010.4578,368,358.71660,575,397.75
        应付股利-23,303,105.8130,806,489.2523,905,106.19
  一年内到期的非流动负债71,107,589.8164,855,107.0360,417,538.7361,077,080.98
  其他流动负债27,022,134.5618,422,113.3913,297,401.129,975,299.38
  流动负债合计1,732,829,381.221,999,138,395.072,138,212,045.842,250,828,854.41
非流动负债:
  长期借款624,876,252.89667,125,639.36643,110,206.4513,813,058.96
  租赁负债4,494,564.446,303,813.315,647,751.25,247,839.55
  递延收益58,456,955.9359,793,790.3960,907,071.5663,132,905.4
  递延所得税负债120,188,332.82131,744,993.92130,931,204.25125,810,337.7
  非流动负债合计808,016,106.08864,968,236.98840,596,233.41708,004,141.61
  负债合计2,540,845,487.32,864,106,632.052,978,808,279.252,958,832,996.02
所有者权益(或股东权益):
  实收资本(或股本)464,754,706464,754,706465,847,906465,847,906
  资本公积2,153,002,323.22,147,521,313.522,157,087,494.682,157,087,494.68
  减:库存股191,211,941.65191,211,941.65191,871,797.65171,875,332.65
  盈余公积233,576,150.02232,923,953232,923,953232,923,953
  未分配利润2,013,038,363.141,907,905,976.141,901,990,815.321,786,006,157.36
  归属于母公司股东权益合计4,673,159,600.714,561,894,007.014,565,978,371.354,469,990,178.39
  少数股东权益476,883,160.94528,980,230.95517,558,540.11536,969,879.46
  股东权益合计5,150,042,761.655,090,874,237.965,083,536,911.465,006,960,057.85
  负债和股东权益合计7,690,888,248.957,954,980,870.018,062,345,190.717,965,793,053.87
公告日期2025-10-252025-08-262025-04-262025-04-03
审计意见(境内)标准无保留意见
TOP↑